Volume | 28,829 |
|
|||||
News | - | ||||||
Day High | 2.3989 | Low High |
|||||
Day Low | 2.25 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Agile Therapeutics Inc | AGRX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.32 | 2.25 | 2.3989 | 2.30 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
191 | 28,829 | $ 2.31 | $ 66,462 | - | 1.65 - 16.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:37:21 | 22 | $ 2.3582 | USD |
Agile Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6M | 2.51M | - | 10.88M | -25.41M | -10.12 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Agile Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGRX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.13 | 2.6063 | 1.98 | 2.33 | 86,885 | 0.15 | 7.04% |
1 Month | 2.00 | 2.6063 | 1.82 | 2.19 | 51,742 | 0.28 | 14.0% |
3 Months | 2.06 | 2.6063 | 1.65 | 2.07 | 43,247 | 0.22 | 10.68% |
6 Months | 3.73 | 4.06 | 1.65 | 2.90 | 80,861 | -1.45 | -38.87% |
1 Year | 10.11 | 16.00 | 1.65 | 11.08 | 282,279 | -7.83 | -77.45% |
3 Years | 156.025 | 218.50 | 1.65 | 47.31 | 2,408,462 | -153.75 | -98.54% |
5 Years | 40.435 | 238.26 | 1.65 | 70.78 | 2,191,485 | -38.16 | -94.36% |
Agile Therapeutics Description
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. |